Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Key Business Regulations to Consider While Arranging Your Independent venture - 2How 2025 became the year of comet: The rise of interstellar 3I/ATLAS, an icy Lemmon and a cosmic SWAN
- 3Israeli strike on Gaza City vehicle kills at least four, report says
- 4Reconnecting with an old friend is a story of distance, loss and rediscovery
- 5A definitive Frozen yogurt Standoff: Which Flavor Rules?
- Vote In favor of Your Favored Kind Of Tea
- She was moments away from giving birth. The hospital discharged her
- These HGTV stars made a pledge to keep their kids off smartphones. Here's how it's going.
- What to expect from the planets in 2026 — key dates and sky events
- Figure out how to Use Your Brain research Degree in the Gig Market
- Instructions to Warmly greet Certainty and Appeal
- Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- Some are walking out. Some are shouting. Some are oblivious. How kids are reacting to THAT 'Wicked: For Good' scene
- Ten Awesome Authentic Realities That Will Leave You Interested
